These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19828320)

  • 1. Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.
    Coudray L; Pennebaker AF; Montchamp JL
    Bioorg Med Chem; 2009 Nov; 17(22):7680-9. PubMed ID: 19828320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.
    Coudray L; Kantrowitz ER; Montchamp JL
    Bioorg Med Chem Lett; 2009 Feb; 19(3):900-2. PubMed ID: 19097895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.
    Eldo J; Heng S; Kantrowitz ER
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2086-90. PubMed ID: 17336518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-phosphonacetyl-L-isoasparagine a potent and specific inhibitor of Escherichia coli aspartate transcarbamoylase.
    Eldo J; Cardia JP; O'Day EM; Xia J; Tsuruta H; Kantrowitz ER
    J Med Chem; 2006 Oct; 49(20):5932-8. PubMed ID: 17004708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli.
    Laing NM; Chan WW; Hutchinson DW; Oberg B
    FEBS Lett; 1990 Jan; 260(2):206-8. PubMed ID: 2153584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
    Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate transcarbamylase from the hyperthermophilic archaeon Pyrococcus abyssi: thermostability and 1.8A resolution crystal structure of the catalytic subunit complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate.
    Van Boxstael S; Cunin R; Khan S; Maes D
    J Mol Biol; 2003 Feb; 326(1):203-16. PubMed ID: 12547202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A.
    Jin L; Stec B; Lipscomb WN; Kantrowitz ER
    Proteins; 1999 Dec; 37(4):729-42. PubMed ID: 10651286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of bisubstrate analog promotes large structural changes in the unregulated catalytic trimer of aspartate transcarbamoylase: implications for allosteric regulation.
    Endrizzi JA; Beernink PT; Alber T; Schachman HK
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5077-82. PubMed ID: 10805770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative binding of the bisubstrate analog N-(phosphonacetyl)-L-aspartate to aspartate transcarbamoylase and the heterotropic effects of ATP and CTP.
    Newell JO; Markby DW; Schachman HK
    J Biol Chem; 1989 Feb; 264(5):2476-81. PubMed ID: 2644262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD.
    Ruiz-Ramos A; Lallous N; Grande-García A; Ramón-Maiques S
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1425-30. PubMed ID: 24316846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution in the active site of Escherichia coli aspartate transcarbamoylase prevents the allosteric transition.
    Stieglitz KA; Pastra-Landis SC; Xia J; Tsuruta H; Kantrowitz ER
    J Mol Biol; 2005 Jun; 349(2):413-23. PubMed ID: 15890205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.
    Farrington GK; Kumar A; Wedler FC
    J Med Chem; 1985 Nov; 28(11):1668-73. PubMed ID: 4067992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase.
    Grison C; Coutrot P; Comoy C; Balas L; Joliez S; Lavecchia G; Oliger P; Penverne B; Serre V; Hervé G
    Eur J Med Chem; 2004 Apr; 39(4):333-44. PubMed ID: 15072842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homotropic effects in aspartate transcarbamoylase. What happens when the enzyme binds a single molecule of the bisubstrate analog N-phosphonacetyl-L-aspartate?
    Foote J; Schachman HK
    J Mol Biol; 1985 Nov; 186(1):175-84. PubMed ID: 3908690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and Functional Characterization of Human Aspartate Transcarbamoylase, the Target of the Anti-tumoral Drug PALA.
    Ruiz-Ramos A; Velázquez-Campoy A; Grande-García A; Moreno-Morcillo M; Ramón-Maiques S
    Structure; 2016 Jul; 24(7):1081-94. PubMed ID: 27265852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 70-amino acid zinc-binding polypeptide fragment from the regulatory chain of aspartate transcarbamoylase causes marked changes in the kinetic mechanism of the catalytic trimer.
    Zhou BB; Waldrop GL; Lum L; Schachman HK
    Protein Sci; 1994 Jun; 3(6):967-74. PubMed ID: 8069226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of N-(phosphonacetyl)-L-aspartate to aspartate carbamoyltransferase of Escherichia coli.
    Volź KW; Krause KL; Lipscomb WN
    Biochem Biophys Res Commun; 1986 Apr; 136(2):822-6. PubMed ID: 3518720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate transcarbamylase (ATCase) of Escherichia coli: a new crystalline R-state bound to PALA, or to product analogues citrate and phosphate.
    Huang J; Lipscomb WN
    Biochemistry; 2004 Jun; 43(21):6415-21. PubMed ID: 15157075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C isotope effect studies of Escherichia coli aspartate transcarbamylase in the presence of the bisubstrate analog N-(phosphonoacetyl)-L-aspartate.
    Parmentier LE; O'Leary MH; Schachman HK; Cleland WW
    Biochemistry; 1992 Jul; 31(28):6598-602. PubMed ID: 1633172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.